Skip to content
Search

Latest Stories

British Skin Foundation, ITN Productions Industry News to co-produce new programme

The British Skin Foundation and ITN Productions Industry News are jointly producing ‘The Ages of our Skin’, a news-style programme taking an unfiltered look at skin across all age groups.

The programme, anchored by an ITN Productions Industry New presenter from their London Studios, will raise awareness and understanding of different skin conditions and the importance of skin care across all ages.


With a combination of interviews of the industry figures, news-style reports and sponsored editorial profiles from leading organisations and industry innovators, it will address the myths and misinformation with scientific advice from industry experts.

Matthew Patey, CEO of the foundation said: “Following a successful campaign with ITN Productions Industry News in 2021, the British Skin Foundation are excited to be collaborating again on a brand-new project. The skin is the body’s largest organ and it’s important to take care of it throughout our entire lives. We’re looking forward to exploring ‘The Ages of our Skin’ alongside our experts in 2022.”

Commenting on the joint production, Nina Harrison-Bell head of ITN Productions Industry News said the new programme would throw light on the “exciting research and developments leading dermatology into the future.”

The show will cover people with different skin conditions and will talk about what more needs to be done to prevent stigma associated with various skin types, alongside highlighting the BSF’s role in funding research into advancements of treatment and cures.

It will be launched at the British Association of Dermatologists’ Annual Conference taking place on July 5, 2022 at the SEC, Glasgow and will be supported by an extensive marketing communications campaign led by BSF and supported by ITN Productions.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less